Stoke Therapeutics (STOK)
Develops antisense medicines that restore protein expression in severe genetic diseases.
$26.63
vs last close−2.57 (−8.80%)
Something off on this page? Send us feedback.
Next report
Nov 3, 26
in 41 days
EPS estimate
−$0.88
Revenue estimate
$8.2M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.18$1.90−$0.40−$0.65−$0.97−$0.79−$0.93Pending
Estimate−$0.51−$0.37−$0.57−$0.54−$0.75−$0.80−$0.80−$0.88
Surprise+64.7%+613.5%+29.8%−20.4%−29.3%+1.3%−17.0%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$22.6M$158.6M$13.8M$10.6M$1.4M$6.2M$9.3MPending
Estimate$3.9M$31.5M$5.4M$4.6M$5.8M$6.5M$4.9M$8.2M
Surprise+485.9%+403.2%+158.0%+133.4%−76.0%−3.9%+90.7%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.88 | — | — |
| Sep 2027 | −$0.91 | — | — |
| Jun 2027 | −$0.97 | — | — |
| Mar 2027 | −$0.96 | — | — |
| Dec 2026 | −$0.97 | — | — |
| Nov 2026 | −$0.88 | — | — |
| Aug 2026 | −$0.80 | −$0.93 | −17.0% |
| May 2026 | −$0.80 | −$0.79 | +1.3% |
| Mar 2026 | −$0.75 | −$0.97 | −29.3% |
| Nov 2025 | −$0.54 | −$0.65 | −20.4% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| Mar 2019 | |||
| Jun 2019 | |||
| Sep 2018 | |||
| Jun 2018 | |||
| Mar 2018 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.88 | — | — | $7.5M | — | — | — |
| Sep 2027 | −$0.91 | — | — | $7.4M | — | — | — |
| Jun 2027 | −$0.97 | — | — | $6.9M | — | — | — |
| Mar 2027 | −$0.96 | — | — | $6.8M | — | — | — |
| Dec 2026 | −$0.97 | — | — | $8.2M | — | — | — |
| Nov 3, 2026 | −$0.88 | — | — | $8.2M | — | — | — |
| Aug 3, 2026 | −$0.80 | −$0.93 | −17.0% | $4.9M | $9.3M | +90.7% | +7.1% |
| May 7, 2026 | −$0.80 | −$0.79 | +1.3% | $6.5M | $6.2M | −3.9% | +0.3% |
| Mar 16, 2026 | −$0.75 | −$0.97 | −29.3% | $5.8M | $1.4M | −76.0% | +2.3% |
| Nov 4, 2025 | −$0.54 | −$0.65 | −20.4% | $4.6M | $10.6M | +133.4% | −9.9% |
| Aug 12, 2025 | |||||||
| May 13, 2025 | |||||||
| Mar 18, 2025 | |||||||
| Nov 5, 2024 | |||||||
| Aug 7, 2024 | |||||||
| May 6, 2024 | |||||||
| Mar 25, 2024 | |||||||
| Nov 7, 2023 | |||||||
| Aug 7, 2023 | |||||||
| May 4, 2023 | |||||||
| Mar 6, 2023 | |||||||
| Nov 14, 2022 | |||||||
| Aug 8, 2022 | |||||||
| May 10, 2022 | |||||||
| Mar 10, 2022 | |||||||
| Nov 8, 2021 | |||||||
| Aug 10, 2021 | |||||||
| May 10, 2021 | |||||||
| Mar 9, 2021 | |||||||
| Nov 12, 2020 | |||||||
| Aug 10, 2020 | |||||||
| May 15, 2020 | |||||||
| Feb 24, 2020 | |||||||
| Nov 12, 2019 | |||||||
| Aug 14, 2019 | |||||||
| Mar 31, 2019 | |||||||
| Jun 19, 2019 | |||||||
| Sep 30, 2018 | |||||||
| Jun 30, 2018 | |||||||
| Mar 31, 2018 |